BACKGROUND: Bone marrow lesions (BMLs) of the knee have become a common finding on magnetic resonance imaging (MRI), leading to a growing interest in BML, not only for its potential role in the progression of several musculoskeletal conditions, but also for its clinical impact and treatment implications. At present, there is limited and conflicting evidence regarding whether or not pain may be correlated to BML size or not. AIM: To verify the longitudinal correlation between BML size and knee pain. DESIGN: Longitudinal. SETTING: The study was conducted from January to December 2013, at the Galeazzi Institute of Orthopedics in Milan, Italy. POPULATION: The study sample was composed of 72 patients, 27 males and 45 females, with a mean age of 55.9 ± 10.22 years and a mean BMI of 26.1 ± 3.7 kg/m2. All patients presented with BMLs and acute knee pain. METHODS: All 72 patients underwent a knee MRI before and 6 months after a course of high energy ESWT, in order to perform a quantitative measurement of the BML areas. KOOS (Knee Injury and Osteoarthritis Outcome Score) Pain subscale scores were obtained at the same time point. A regression analysis was performed to verify the correlation between knee BML size and KOOS pain subscale score before treatment and the correlation between the reduction of BML size and the improvement of KOOS pain score 6 months after treatment. RESULTS: A statistically significant correlation between the KOOS Pain sub scale and the BML size (beta = -0.362 [CI95%: -0.019/-0.05], p = 0.002) was demonstrated. The clinical score and BML area significantly improved after treatment (p<0.001). The clinical improvement was correlated to the BML size reduction (beta = 0.254 [CI95%: 0.001/0.017], p = 0.031). CONCLUSIONS: This study confirmed a significant correlation between the BML size and the intensity of knee pain. Furthermore, the before and after study using ESWT to treat symptomatic BMLs, revealed a correlation between size reduction of BML and KOOS pain subscale score improvement, demonstrating the utility of BML reduction as a therapeutic goal. Finally, ESWT was validated as a safe and potentially effective treatment of subchondral bone marrow lesions. CLINICAL REHABILITATION IMPACT: Our results confirm that severity of pain is correlated with BML size, and furthermore, demonstrate that increases and decreases in the amount of pain reflect growth or reduction in BML size, respectively. This information may be useful for rehabilitation and decrease the reliance on MRIs for checking the progress of bone lesions. Absence or marked reduction of pain should allow for the resumption of weight-bearing and more strenuous exercises for an adequate musculoskeletal recovery.

Bone marrow lesions of the knee: longitudinal correlation between lesion size changes and pain before and after conservative treatment by extracorporeal shockwave therapy / V. Sansone, E. Maiorano, V. Pascale, P. Romeo. - In: EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE. - ISSN 1973-9095. - 55:2(2019 Apr 02), pp. 225-230. [10.23736/S1973-9087.18.05036-0]

Bone marrow lesions of the knee: longitudinal correlation between lesion size changes and pain before and after conservative treatment by extracorporeal shockwave therapy

V. Sansone
Primo
;
E. Maiorano
Secondo
;
V. Pascale
Penultimo
;
2019

Abstract

BACKGROUND: Bone marrow lesions (BMLs) of the knee have become a common finding on magnetic resonance imaging (MRI), leading to a growing interest in BML, not only for its potential role in the progression of several musculoskeletal conditions, but also for its clinical impact and treatment implications. At present, there is limited and conflicting evidence regarding whether or not pain may be correlated to BML size or not. AIM: To verify the longitudinal correlation between BML size and knee pain. DESIGN: Longitudinal. SETTING: The study was conducted from January to December 2013, at the Galeazzi Institute of Orthopedics in Milan, Italy. POPULATION: The study sample was composed of 72 patients, 27 males and 45 females, with a mean age of 55.9 ± 10.22 years and a mean BMI of 26.1 ± 3.7 kg/m2. All patients presented with BMLs and acute knee pain. METHODS: All 72 patients underwent a knee MRI before and 6 months after a course of high energy ESWT, in order to perform a quantitative measurement of the BML areas. KOOS (Knee Injury and Osteoarthritis Outcome Score) Pain subscale scores were obtained at the same time point. A regression analysis was performed to verify the correlation between knee BML size and KOOS pain subscale score before treatment and the correlation between the reduction of BML size and the improvement of KOOS pain score 6 months after treatment. RESULTS: A statistically significant correlation between the KOOS Pain sub scale and the BML size (beta = -0.362 [CI95%: -0.019/-0.05], p = 0.002) was demonstrated. The clinical score and BML area significantly improved after treatment (p<0.001). The clinical improvement was correlated to the BML size reduction (beta = 0.254 [CI95%: 0.001/0.017], p = 0.031). CONCLUSIONS: This study confirmed a significant correlation between the BML size and the intensity of knee pain. Furthermore, the before and after study using ESWT to treat symptomatic BMLs, revealed a correlation between size reduction of BML and KOOS pain subscale score improvement, demonstrating the utility of BML reduction as a therapeutic goal. Finally, ESWT was validated as a safe and potentially effective treatment of subchondral bone marrow lesions. CLINICAL REHABILITATION IMPACT: Our results confirm that severity of pain is correlated with BML size, and furthermore, demonstrate that increases and decreases in the amount of pain reflect growth or reduction in BML size, respectively. This information may be useful for rehabilitation and decrease the reliance on MRIs for checking the progress of bone lesions. Absence or marked reduction of pain should allow for the resumption of weight-bearing and more strenuous exercises for an adequate musculoskeletal recovery.
knee; bone marrow lesions; magnetic resonance imaging; koos pain subscale; extracorporeal shock wave therapy; conservative treatment
Settore MED/33 - Malattie Apparato Locomotore
2-apr-2019
27-ago-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
R33Y9999N00A18082704.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 519.97 kB
Formato Adobe PDF
519.97 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/597104
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
social impact